legislation: 96-hr-7675

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
96-hr-7675 96 hr 7675 A bill to direct the National Institute of Arthritis, Metabolism, and Digestive Diseases to conduct such studies as may be necessary to determine the safety and efficacy under section 505 of the Federal Food, Drug, and Cosmetic Act of dimethylsulfoxide (DMSO) as a topical analgesic and to provide that, if the drug is so determined to be safe and effective, new drug applications may be approved under such section based on the evidence submitted by the Institute. Health 1980-06-26 1980-06-26 Referred to House Committee on Interstate and Foreign Commerce. House Rep. Heckler, Margaret M. [R-MA-10] MA R H000440 0 Requires the Director of the National Institute of Arthritis, Metabolism, and Digestive Diseases to conduct such studies as are necessary to determine the safety and efficacy of dimethyl sulfoxide as a topical analgesic. Requires the submission and approval by the Secretary of Health and Human Services of a new drug application should such investigations prove the safety and efficacy of such substance for its intended use. 2024-02-05T14:30:09Z  

Links from other tables